Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.

Yarbrough WG, Panaccione A, Chang MT, Ivanov SV.

Laryngoscope Investig Otolaryngol. 2016 Aug 4;1(4):60-77. doi: 10.1002/lio2.22. eCollection 2016 Aug. Review.


Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast.

Kovács A, Persson F, Persson M, Andersson MK, Stenman G.

Mol Clin Oncol. 2017 Sep;7(3):322-326. doi: 10.3892/mco.2017.1330. Epub 2017 Jul 18.


Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma.

Sant DW, Tao W, Field MG, Pelaez D, Jin K, Capobianco A, Dubovy SR, Tse DT, Wang G.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO240-BIO246. doi: 10.1167/iovs.16-21097.


Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.

Pareja F, Geyer FC, Marchiò C, Burke KA, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2016 Nov 16;2:16036. doi: 10.1038/npjbcancer.2016.36. eCollection 2016. Review.


Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.

Xu B, Drill E, Ho A, Ho A, Dunn L, Prieto-Granada CN, Chan T, Ganly I, Ghossein R, Katabi N.

Am J Surg Pathol. 2017 Oct;41(10):1422-1432. doi: 10.1097/PAS.0000000000000918.


Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.

Becker-Santos DD, Lonergan KM, Gronostajski RM, Lam WL.

EBioMedicine. 2017 Aug;22:2-9. doi: 10.1016/j.ebiom.2017.05.027. Epub 2017 May 27. Review.


MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.

Panaccione A, Zhang Y, Ryan M, Moskaluk CA, Anderson KS, Yarbrough WG, Ivanov SV.

Stem Cell Res. 2017 May;21:160-166. doi: 10.1016/j.scr.2017.05.002. Epub 2017 May 5.


A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.

Goncalves PH, Heilbrun LK, Barrett MT, Kummar S, Hansen AR, Siu LL, Piekarz RL, Sukari AW, Chao J, Pilat MJ, Smith DW, Casetta L, Boerner SA, Chen A, Lenkiewicz E, Malasi S, LoRusso PM.

Oncotarget. 2017 May 16;8(20):32918-32929. doi: 10.18632/oncotarget.16464.


A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Dillon PM, Petroni GR, Horton BJ, Moskaluk CA, Fracasso PM, Douvas MG, Varhegyi N, Zaja-Milatovic S, Thomas CY.

Clin Cancer Res. 2017 Aug 1;23(15):4138-4145. doi: 10.1158/1078-0432.CCR-16-2942. Epub 2017 Apr 4.


Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.

Eliyatkın N, Yalçın E, Zengel B, Aktaş S, Vardar E.

J Breast Health. 2015 Apr 1;11(2):59-66. doi: 10.5152/tjbh.2015.1669. eCollection 2015 Apr. Review.


Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.

Geyer FC, Burke KA, Piscuoglio S, Ng CKY, Papanastasiou AD, Marchiò C, Selenica P, Edelweiss M, Murray MP, Brogi E, Soslow RA, Rubin BP, Norton L, Reis-Filho JS, Weigelt B.

Mol Oncol. 2017 Aug;11(8):913-926. doi: 10.1002/1878-0261.12049. Epub 2017 May 16.


Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Seethala RR, Stenman G.

Head Neck Pathol. 2017 Mar;11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28.


NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.

Fane ME, Chhabra Y, Hollingsworth DE, Simmons JL, Spoerri L, Oh TG, Chauhan J, Chin T, Harris L, Harvey TJ, Muscat GE, Goding CR, Sturm RA, Haass NK, Boyle GM, Piper M, Smith AG.

EBioMedicine. 2017 Feb;16:63-75. doi: 10.1016/j.ebiom.2017.01.013. Epub 2017 Jan 16.


Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.

Chen TY, Keeney MG, Chintakuntlawar AV, Knutson DL, Kloft-Nelson S, Greipp PT, Garrity JA, Salomao DR, Garcia JJ.

Eye (Lond). 2017 May;31(5):720-725. doi: 10.1038/eye.2016.307. Epub 2017 Jan 13.


Genomic sequencing and precision medicine in head and neck cancers.

Hoesli RC, Ludwig ML, Michmerhuizen NL, Rosko AJ, Spector ME, Brenner JC, Birkeland AC.

Eur J Surg Oncol. 2017 May;43(5):884-892. doi: 10.1016/j.ejso.2016.12.002. Epub 2016 Dec 15. Review.


A novel read-through transcript JMJD7-PLA2G4B regulates head and neck squamous cell carcinoma cell proliferation and survival.

Cheng Y, Wang Y, Li J, Chang I, Wang CY.

Oncotarget. 2017 Jan 10;8(2):1972-1982. doi: 10.18632/oncotarget.14081.


IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.

Chiang S, Weigelt B, Wen HC, Pareja F, Raghavendra A, Martelotto LG, Burke KA, Basili T, Li A, Geyer FC, Piscuoglio S, Ng CK, Jungbluth AA, Balss J, Pusch S, Baker GM, Cole KS, von Deimling A, Batten JM, Marotti JD, Soh HC, McCalip BL, Serrano J, Lim RS, Siziopikou KP, Lu S, Liu X, Hammour T, Brogi E, Snuderl M, Iafrate AJ, Reis-Filho JS, Schnitt SJ.

Cancer Res. 2016 Dec 15;76(24):7118-7129. Epub 2016 Oct 20.


Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature.

Prieto-Granada CN, Zhang L, Antonescu CR, Henneberry JM, Messina JL.

J Cutan Pathol. 2017 Feb;44(2):201-209. doi: 10.1111/cup.12856. Epub 2016 Dec 2.


Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting.

Escalante DA, Wang H, Fundakowski CE.

Cancer Biol Ther. 2016 Aug 15:1-8. [Epub ahead of print]


A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

Ho AL, Dunn L, Sherman EJ, Fury MG, Baxi SS, Chandramohan R, Dogan S, Morris LG, Cullen GD, Haque S, Sima CS, Ni A, Antonescu CR, Katabi N, Pfister DG.

Ann Oncol. 2016 Oct;27(10):1902-8. doi: 10.1093/annonc/mdw287. Epub 2016 Aug 26.


Supplemental Content

Support Center